(Q45137694)

9 December 2017

1 reference

title

Antibiotic-induced release of bacterial cell wall components in the pathogenesis of sepsis and septic shock: a review (English)

1 reference

9 December 2017

0 references

0 references

1 reference

1 reference

Periti P

1

1 reference

9 December 2017

Mazzei T

series ordinal

2

1 reference

9 December 2017

language of work or name

1 reference

1 December 1998

1 reference

9 December 2017

published in

Journal of Chemotherapy

1 reference

9 December 2017

volume

10

1 reference

9 December 2017

issue

6

1 reference

9 December 2017

page(s)

427-448

1 reference

Antibiotic-induced endotoxin release from bacteria and its clinical significance

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

The significance of endotoxin release in experimental and clinical sepsis in surgical patients--evidence for antibiotic-induced endotoxin release?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Antibiotic-induced release of endotoxin in chronically bacteriuric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

beta-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Antibiotic-induced release of endotoxin: a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Differential antibiotic-induced release of endotoxin from gram-negative bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Impact of different classes antimicrobial agents on plasma endotoxin activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Differential release of lipoteichoic and teichoic acids from Streptococcus pneumoniae as a result of exposure to beta-lactam antibiotics, rifamycins, trovafloxacin, and quinupristin-dalfopristin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Release of endotoxin from bacteria exposed to ciprofloxacin and its prevention with polymyxin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Antibiotic-induced endotoxin release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Antibiotic killing of bacteria: comparison of bacteria on surfaces and in liquid, growing and nongrowing

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Evaluation of the bactericidal activity of beta-lactam antibiotics on slowly growing bacteria cultured in the chemostat

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Comparison of cefepime, cefpirome, and cefaclidine binding affinities for penicillin-binding proteins in Escherichia coli K-12 and Pseudomonas aeruginosa SC8329

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Postantibiotic effect of beta-lactam antibiotics on Escherichia coli evaluated by bioluminescence assay of bacterial ATP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Abnormal Forms of Bacteria Produced by Antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Penicillin-binding proteins in bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Phagocytosis of staphylococci after exposure to antibiotics, mass versus colony-forming units

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Target for bacteriostatic and bactericidal activities of beta-lactam antibiotics against Escherichia coli resides in different penicillin-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

The role of penicillin-proteins in the action of cephalosporins against Escherichia coli and Salmonella typhimurium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

An evaluation of the bacteriolytic and biochemical properties of ceftiolene (42980RP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Involvement of penicillin-binding protein 2 with other penicillin-binding proteins in lysis of Escherichia coli by some beta-lactam antibiotics alone and in synergistic lytic effect of amdinocillin (mecillinam).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Optimal dosage of beta-lactam antibiotics: time above the MIC and inoculum effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Activity of cefepime against ceftazidime-resistant gram-negative bacilli using low and high inocula.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

The inhibitory quotient. A method for interpreting minimum inhibitory concentration data

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

The post-antibiotic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Post-antibiotic effect of beta-lactam antibiotics on gram-negative bacteria in relation to morphology, initial killing and MIC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Influence of growth rate on susceptibility to antimicrobial agents: modification of the cell envelope and batch and continuous culture studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Preclinical and clinical evaluation of once-daily aminoglycoside chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Clinical relevance of antibiotic-induced endotoxin release

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Antibiotic-induced endotoxin release in patients with gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

The structure and function of Escherichia coli penicillin-binding protein 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Clinical significance of antibiotic endotoxin-releasing properties in trauma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Modulation of bacteriolysis by cooperative effects of penicillin-binding proteins 1a and 3 in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Comparison of the antibacterial effects of cefepime and ceftazidime against Escherichia coli in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Laboratory assessment of antibacterial activity of zwitterionic 7-methoxyimino cephalosporins

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Meropenem: a new carbapenem antimicrobial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Effect of antibiotic class and concentration on the release of lipopolysaccharide from Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Delayed antibiotic-induced lysis of Escherichia coli in vitro is correlated with enhancement of LPS release

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Pharmacokinetics and pharmacodynamics of antibiotics in otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Experience with a once-daily aminoglycoside program administered to 2,184 adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Continuous infusion of beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Is continuous infusion of beta-lactam antibiotics worthwhile?--efficacy and pharmacokinetic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Turbidimetric and microscopic analysis of Bacteroides fragilis exposed to tazobactam and piperacillin alone and in combination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Antibacterial characteristics of YTR 830, a sulfone beta-lactamase inhibitor, compared with those of clavulanic acid and sulbactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

The lethal action of aminoglycosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Natural release of virulence factors in membrane vesicles by Pseudomonas aeruginosa and the effect of aminoglycoside antibiotics on their release

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Release of endotoxin from Escherichia coli by quinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Differences in release of tumor necrosis factor from THP-1 cells stimulated by filtrates of antibiotic-killed Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Effects of aminoglycosides and spectinomycin on the synthesis and release of lipopolysaccharide by Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Inhibition of endotoxin reactivity by aminoglycosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Aminoglycosides modify the in vitro metachromatic reaction and murine generalized Shwartzman phenomenon induced by Salmonella minnesota R595 lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Teicoplanin reduces in-vitro reactivity and murine lethality of Salmonella minnesota R595 lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

Inhibition of endotoxin-induced interleukin 8 release by teicoplanin in human whole blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1998.10.6.427

10.1179/JOC.1998.10.6.427

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference